Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Gliosarcoma × Drug Therapy × Clear all

Phase

Status

Completed 5 Terminated 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Breast Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Anus Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Select Advanced Solid Tumors 1 SCLC 1 Radiation Therapy 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pain 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1

Interventions

Temozolomide 7 sargramostim 2 pembrolizumab 2 Radiation 2 veliparib 1 selinexor 1 montanide ISA 51 1 lonafarnib 1 Vorinostat 1 Utrogestan 1 Sucrose 1 Sonication 1 Sodium Chloride 1 Serotonin Antagonists 1 Salts 1 Radiotherapy 1 Progestins 1 Progesterone 1 Photons 1 Perfusion Magnetic Resonance Imaging 1 Olanzapine 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Loperamide 1 Lomustine 1 Irinotecan 1 Ipilimumab 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Drug Therapy 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04528680 2025-07-31

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡